222 related articles for article (PubMed ID: 24803988)
1. Olive (Olea europaea) leaf extract induces apoptosis and monocyte/macrophage differentiation in human chronic myelogenous leukemia K562 cells: insight into the underlying mechanism.
Samet I; Han J; Jlaiel L; Sayadi S; Isoda H
Oxid Med Cell Longev; 2014; 2014():927619. PubMed ID: 24803988
[TBL] [Abstract][Full Text] [Related]
2. The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract.
Fares R; Bazzi S; Baydoun SE; Abdel-Massih RM
Plant Foods Hum Nutr; 2011 Mar; 66(1):58-63. PubMed ID: 21318304
[TBL] [Abstract][Full Text] [Related]
3. Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract.
Abaza L; Talorete TP; Yamada P; Kurita Y; Zarrouk M; Isoda H
Biosci Biotechnol Biochem; 2007 May; 71(5):1306-12. PubMed ID: 17485840
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Efficacy of Olive Leaf (
Albogami S; Hassan AM
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279409
[TBL] [Abstract][Full Text] [Related]
5. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
Yen JH; Lin CY; Chuang CH; Chin HK; Wu MJ; Chen PY
Cells; 2020 Apr; 9(4):. PubMed ID: 32260160
[TBL] [Abstract][Full Text] [Related]
6. The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis.
Morandi F; Bensa V; Calarco E; Pastorino F; Perri P; Corrias MV; Ponzoni M; Brignole C
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202787
[TBL] [Abstract][Full Text] [Related]
7. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
[TBL] [Abstract][Full Text] [Related]
8. Differential metabolomic analysis of the potential antiproliferative mechanism of olive leaf extract on the JIMT-1 breast cancer cell line.
Barrajón-Catalán E; Taamalli A; Quirantes-Piné R; Roldan-Segura C; Arráez-Román D; Segura-Carretero A; Micol V; Zarrouk M
J Pharm Biomed Anal; 2015 Feb; 105():156-162. PubMed ID: 25560707
[TBL] [Abstract][Full Text] [Related]
9. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells.
Wang L; Jiang R; Song SD; Hua ZS; Wang JW; Wang YP
Asian Pac J Cancer Prev; 2015; 16(9):3715-21. PubMed ID: 25987027
[TBL] [Abstract][Full Text] [Related]
10. Phytochemical properties and anti-proliferative activity of Olea europaea L. leaf extracts against pancreatic cancer cells.
Goldsmith CD; Vuong QV; Sadeqzadeh E; Stathopoulos CE; Roach PD; Scarlett CJ
Molecules; 2015 Jul; 20(7):12992-3004. PubMed ID: 26193251
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
12. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
13. Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells.
Lee KW; Um ES; Jung BB; Choi ES; Kim EY; Lee S; Jang E; Lee JH; Kim Y
Oncol Rep; 2018 Mar; 39(3):1141-1147. PubMed ID: 29328387
[TBL] [Abstract][Full Text] [Related]
14. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
15. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
16. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
Yandim MK; Ceylan C; Elmas E; Baran Y
Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.
Shi D; Liu Y; Xi R; Zou W; Wu L; Zhang Z; Liu Z; Qu C; Xu B; Wang X
Int J Nanomedicine; 2016; 11():5823-5835. PubMed ID: 27853367
[TBL] [Abstract][Full Text] [Related]
18. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
Jacquel A; Herrant M; Legros L; Belhacene N; Luciano F; Pages G; Hofman P; Auberger P
FASEB J; 2003 Nov; 17(14):2160-2. PubMed ID: 14597677
[No Abstract] [Full Text] [Related]
19. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
Shiotsu Y; Neckers LM; Wortman I; An WG; Schulte TW; Soga S; Murakata C; Tamaoki T; Akinaga S
Blood; 2000 Sep; 96(6):2284-91. PubMed ID: 10979978
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
